The goal of this observational study is to evaluate the feasibility of a systematic screening protocol for Obstructive Sleep Apnea (OSA) during preoperative anesthesia consultations in adults aged 50 and older undergoing elective surgery. The main questions it aims to answer are: * Does the systematic screening protocol increase the proportion of patients identified as being at high risk for OSA compared to standard care? * What is the impact of systematic screening on postoperative outcomes, including complications, length of stay, and mortality? Researchers will compare standard care practices (before implementation) to the systematic screening protocol (after implementation) to determine the effect on OSA detection rates and clinical outcomes. Participants will: * Complete the STOP-BANG questionnaire during their anesthesia consultation. * (Optional) Have a facial photograph taken to analyze morphometric characteristics that may correlate with OSA risk. * Be referred for further diagnostic testing if identified as high-risk for OSA.
Study Type
OBSERVATIONAL
Enrollment
150
Hopital Privé Claude Galien
Quincy-sous-Sénart, France
proportion of participants in whom the risk of OSA (Obstructive Sleep Apnea Syndrome) was detected in the control group before versus the group after
Time frame: From enrollment to the end of treatment at 7 months
Mortality at 3 months.
Time frame: From enrollment to the end of treatment at 7 months
Postoperative length of stay.
Time frame: From enrollment to the end of treatment at 7 months
Sensitivity, specificity, and concordance rate of OSA (Obstructive Sleep Apnea Syndrome) detection.
Time frame: From enrollment to the end of treatment at 7 months
Correlation between facial morphotype and OSA diagnosis with and without facial morphotype measurement.
Time frame: From enrollment to the end of treatment at 7 months
Postoperative complications and mortality at 3 months.
Time frame: From enrollment to the end of treatment at 7 months
Postoperative complications
Pulmonary event Cardiac event Kidney event Vascular event
Time frame: From enrollment to the end of treatment at 7 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.